Biofrontera AG pivotal Phase III data demonstrate significant efficacy and excellent safety for BF-200 ALA treatment of superficial skin cancer
2/15/2016

Biofrontera AG (FSE: B8F), the specialist for sun-induced skin cancer, presented data from three pivotal Phase III trials for its lead drug candidate BF-200 ALA at the 14th Annual South Beach...

Saliva test for identifying, tracking cancer steps closer
2/15/2016

Researchers are developing a non-invasive, 10-minute test that detects cancer in just a drop of saliva that could be performed in a doctor's office.

Interferon not beneficial for most stage III melanoma
2/15/2016

Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do...

Light used to measure the 'big stretch' in spider silk proteins
2/15/2016

While working to improve a tool that measures the pushes and pulls sensed by proteins in living cells, biophysicists at Johns Hopkins say they've discovered one reason spiders' silk is so elastic...

Progress in fighting cancer and infections with T cell therapy
2/15/2016

The quest to bring immunotherapy into widespread clinical use against cancer and infectious diseases has made great strides in recent years.

Interferon not beneficial for most stage III melanoma
2/15/2016

Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do...

New nanotechnology detects biomarkers of cancer
2/15/2016

Researchers at Wake Forest Baptist Medical Center have developed a new technology to detect disease biomarkers in the form of nucleic acids, the building blocks of all living organisms.

Study finds mechanism by which obesity promotes pancreatic and breast cancer
2/15/2016

Suppression of metastasis-promoting microenvironment by blocking signaling pathway may be particularly effective in obese patients.

Registry data used to examine gender gaps in blood thinners, appropriate use
2/15/2016

The American College of Cardiology's National Cardiovascular Data Registry was the source of data for several research studies published in the final three months of 2015, including a study...

Registry data used to examine gender gaps in blood thinners, appropriate use
2/15/2016

The American College of Cardiology's National Cardiovascular Data Registry was the source of data for several research studies published in the final three months of 2015, including a study...